As of April 18, 2025, Nicox S.A. (ALCOX.PA) has a market cap of $17.971 million USD. According to our data, Nicox S.A. is ranked No.8598 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $17.97 M |
-18.68%
|
Dec 31, 2024 | $22.10 M |
-36.43%
|
Dec 29, 2023 | $34.76 M |
-60.54%
|
Dec 30, 2022 | $88.09 M |
-56.16%
|
Dec 31, 2021 | $0.20 B |
-41.26%
|
Dec 31, 2020 | $0.34 B |
-0.11%
|
Dec 31, 2019 | $0.34 B |
-13.07%
|
Dec 31, 2018 | $0.39 B |
-50.59%
|
Dec 29, 2017 | $0.80 B |
18.86%
|
Dec 30, 2016 | $0.67 B |
-7.06%
|
Dec 30, 2015 | $0.72 B |
-1.46%
|
Dec 31, 2014 | $0.73 B |
-22.41%
|
Dec 31, 2013 | $0.94 B |
3.05%
|
Dec 28, 2012 | $0.92 B |
129.56%
|
Dec 30, 2011 | $0.40 B |
-54.07%
|
Dec 30, 2010 | $0.87 B |
3,692.69%
|
Dec 31, 2009 | $22.91 M |
-12.96%
|
Dec 31, 2008 | $26.33 M |
-29.45%
|
Dec 31, 2007 | $37.32 M |
-51.84%
|
Dec 29, 2006 | $77.49 M |
547.03%
|
Dec 30, 2005 | $11.98 M |
-15.35%
|
Dec 31, 2004 | $14.15 M |
-98.74%
|
Dec 31, 2003 | $1.12 B |
2,257.14%
|
Dec 31, 2002 | $47.50 M |
-14.08%
|
Dec 31, 2001 | $55.28 M |
-40.32%
|
Dec 29, 2000 | $92.62 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Novartis
NVS
|
$219.89 B |
0.932 B
|
![]() Switzerland
|
![]() Bausch Health
BHC
|
$1.88 B |
0.153 M
|
![]() Canada
|
![]() Santen Pharmaceutical
4536.T
|
$3.38 B |
56.434 M
|
![]() Japan
|
![]() Alcon
ALC
|
$45.80 B |
29.056 M
|
![]() Switzerland
|
![]() Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$72.79 B |
-0.000 M
|
![]() UK
|
![]() Pfizer
PFE
|
$125.57 B |
0.001 M
|
![]() USA
|
![]() Sanofi
SNY
|
$124.64 B |
0.327 B
|
![]() France
|
![]() AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
![]() UK
|
![]() Merck
MRK
|
$196.28 B |
0.008 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$306.02 B |
0.008 M
|
![]() USA
|
Market Cap | = | ALCOX.PA Stock Price | * | ALCOX.PA Shares Outstanding |
= | $0.26 | * | 69.01 M | |
= | $17.97 M |